Investor Presentaiton
Near Term Growth Catalysts with Four Commercial Products to be Launched
in 2023/2024
TIL: IND to BLA
✓ 2015-Present
✓ 450+ Clinical Batches
✓ 1000+ Potency Tests
✓ Commercial Supply at
more than 300 batches
/ year starting late 2023
Plasmid & LVV: IND to
BLA
2018-Present
✓ 8 Months from project
start to IND
✓ CDE on-site inspection
completed in March
2023
✓ Commercial Supply to
start upon NMPA
approval
CAR-T: To Provide
Commercial Supply
✓ 2023-Present
✓ Tech transfer to PAS
filing 14 months
✓ Commercial Supply
Launch at 1000+
batches/year starting
2H-2024
✓ Ramping up to more
batches / year by 2026
✓
LVV: Commerical
Supply for CAR-T
2020-Present
✓ PPQ in progress
✓
Post PPQ supply starting
in early 2024
✓ FDA PAI submission in
1H 2024
✓ Commercial supply at
40-120 batches / year
starting 2H-2024
Full Regulatory Support for IND/BLA Filing; PLI (Inspection) Readiness Leading to Commercialization
? Wuxi AppTec
药明康德View entire presentation